Medicare Mastectomy Coverage Policy: A Payer Operations Guide

Medicare Parts A and B: Foundational Coverage for Mastectomy

Medicare Part A primarily covers inpatient hospital services, including the facility charges associated with a mastectomy performed during an inpatient stay. For services rendered in an outpatient setting, such as an Ambulatory Surgical Center (ASC) or physician's office, Medicare Part B is the primary payer. This distinction is critical for correct billing and understanding patient cost-sharing responsibilities, including deductibles and coinsurance.

Covered Mastectomy Procedures and Medical Necessity

Medicare generally covers medically necessary mastectomies performed for the treatment of breast cancer or for high-risk individuals meeting specific criteria. Coverage extends to various surgical approaches, including simple, modified radical, skin-sparing, and nipple-sparing mastectomies. The determination of medical necessity relies heavily on clinical documentation, including pathology reports, genetic testing results, and physician notes outlining the diagnostic findings and treatment plan. Prophylactic mastectomies for individuals at high genetic risk (e.g., BRCA1/2 mutations) are typically covered when supported by robust clinical evidence and genetic counseling.

The Women's Health and Cancer Rights Act (WHCRA) of 1998

The Women's Health and Cancer Rights Act (WHCRA) mandates that group health plans, including Medicare, that cover mastectomies also cover certain post-mastectomy benefits. This critical legislation ensures coverage for all stages of reconstruction of the breast on which the mastectomy was performed, surgery and reconstruction of the other breast to produce a symmetrical appearance, prostheses, and treatment of physical complications at all stages of the mastectomy, including lymphedema. WHCRA applies to both original Medicare and Medicare Advantage plans. Health plans must inform beneficiaries of these rights upon enrollment and annually.

Reconstructive Options and Coverage

Under WHCRA, Medicare covers various reconstructive options, including breast implants (saline or silicone) and autologous tissue reconstruction (e.g., TRAM flap, DIEP flap). The choice of reconstructive method is a clinical decision between the patient and surgeon, with Medicare coverage generally following the medical necessity of the reconstruction itself, not the specific technique. It is essential that documentation clearly supports the reconstructive intent as per WHCRA guidelines, not purely cosmetic enhancement.

External Prostheses and Garments

WHCRA also ensures coverage for external breast prostheses and mastectomy bras. These are typically billed under Medicare Part B as durable medical equipment (DME) or prosthetics. Specific HCPCS codes apply, and documentation must confirm the medical necessity for these items following a mastectomy. Regular replacement of prostheses is also covered, subject to reasonable useful lifetime guidelines.

Prior Authorization and Documentation Requirements

While original Medicare generally does not require prior authorization for most Part B services, certain procedures, especially those with high costs or potential for misuse, may be subject to specific NCDs/LCDs that outline medical necessity criteria. Medicare Advantage (Part C) plans, however, frequently require prior authorization for mastectomy and reconstructive procedures. These plans often utilize proprietary medical policies or third-party reviewers like eviCore or Carelon. Submitting a clean X12 278 transaction with comprehensive clinical notes, pathology reports, and a detailed plan of care is critical for approval.

Key Documentation Elements for Mastectomy Claims

• Pathology report confirming malignancy or high-risk status.
• Operative report detailing the procedure performed.
• Physician orders and progress notes supporting medical necessity.
• Genetic counseling reports and testing results for prophylactic cases.
• Pre-operative imaging and diagnostic reports.
• Documentation of discussion with the patient regarding reconstructive options, per WHCRA.

Coding and Billing Precision for Mastectomy Services

Accurate ICD-10-CM diagnosis codes and CPT procedure codes are paramount for successful mastectomy claims. Diagnosis codes must reflect the specific type of breast cancer (e.g., C50.x for malignant neoplasm of breast) or high-risk condition (e.g., Z15.01 for genetic susceptibility to malignant neoplasm of breast). CPT codes for mastectomy vary based on the surgical extent (e.g., 19301 for simple, 19303 for radical modified). Reconstructive procedures also have specific CPT codes (e.g., 19361 for TRAM flap, 19342 for delayed insertion of breast prosthesis). Modifier usage, such as -50 for bilateral procedures, must adhere to Medicare guidelines. Incorrect coding is a frequent cause of claim denial.

Addressing Denials and the Appeals Process

Mastectomy claims can be denied for various reasons, including lack of medical necessity, insufficient documentation, or incorrect coding. When a denial occurs, a prompt and structured appeals process is necessary. For original Medicare, this involves several levels: redetermination by the Medicare Administrative Contractor (MAC), reconsideration by a Qualified Independent Contractor (QIC), hearing by an Administrative Law Judge (ALJ), review by the Medicare Appeals Council, and finally, judicial review in federal district court. Medicare Advantage plans have their own internal appeals processes, followed by external review. Detailed clinical rationale and supporting documentation are essential at each appeal level. Utilizing tools that track denial trends can help identify common issues and refine pre-authorization and documentation workflows.